Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
Detection Principle
ImmunoAssay-Antibody
Target
IgG vs S (Euroimmun); IgG vs N (Epitope, Roche)
Testing Method Category
Testing Method
Multiple kits
Testing Method - Additional Info
ELISA kits: anti-SARS-CoV-2 IgG ELISA (Lot:E200429AG, Euroimmun, Germany), EDITM Novel Coronavirus COVID-19 IgG ELISA (Lot:P745U, Epitope Diagnostics, United States) ; ECLIA (electrochemiluminescence immunoassay) kit: Elecsys Anti-SARS-CoV-2 (Lot:496298, Roche, Germany).
Reported Performance
Sensitivity: 92.3% (Roche), 96.2–100% (Euroimmun), 100% (Epitope); specificity: 100% (Roche), 100% (Euroimmun), 84–86% (Epitope)
Sample Size
51 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements